{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:10:24Z","timestamp":1776132624377,"version":"3.50.1"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.neuropharm.2022.109272","type":"journal-article","created":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T09:33:53Z","timestamp":1664098433000},"page":"109272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Depression and antidepressant effects of ketamine and its metabolites: The pivotal role of gut microbiota"],"prefix":"10.1016","volume":"220","author":[{"given":"Hao","family":"Hua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zifeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cunming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1540-4385","authenticated-orcid":false,"given":"Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109272_bib1","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.psyneuen.2012.03.024","article-title":"Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats","volume":"37","author":"Ait-Belgnaoui","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2022.109272_bib2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jad.2016.05.038","article-title":"Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder","volume":"202","author":"Aizawa","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109272_bib3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.intimp.2018.11.037","article-title":"On the role of corticosterone in behavioral disorders, microbiota composition alteration and neuroimmune response in adult male mice subjected to maternal separation stress","volume":"66","author":"Amini-Khoei","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.neuropharm.2022.109272_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1476-5381.1983.tb11031.x","article-title":"The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate","volume":"79","author":"Anis","year":"1983","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109272_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239234","article-title":"Bacterial metabolites of human gut microbiota correlating with depression","volume":"21","author":"Averina","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109272_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0960-0760(91)90284-C","article-title":"Cytokines as modulators of the hypothalamus-pituitary-adrenal axis","volume":"40","author":"Besedovsky","year":"1991","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2022.109272_bib8","doi-asserted-by":"crossref","first-page":"G80","DOI":"10.1152\/ajpgi.00448.2016","article-title":"Human-derived gut microbiota modulates colonic secretion in mice by regulating 5-HT(3) receptor expression via acetate production","volume":"313","author":"Bhattarai","year":"2017","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.neuropharm.2022.109272_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.46","article-title":"Increased M1\/decreased M2 signature and signs of Th1\/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia","volume":"4","author":"Brambilla","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109272_bib10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.biopsych.2016.12.031","article-title":"Targeting the microbiota-gut-brain Axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice","volume":"82","author":"Burokas","year":"2017","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061270","article-title":"Role of serotonergic system in the antidepressant actions of mGlu2\/3 receptor antagonists: similarity to ketamine","volume":"20","author":"Chaki","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109272_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainresbull.2022.02.004","article-title":"Brain-gut-microbiota axis in depression: a historical overview and future directions","volume":"182","author":"Chang","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2022.109272_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.psychres.2018.08.078","article-title":"Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: a randomized, double-blind control study","volume":"269","author":"Chen","year":"2018","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2022.109272_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2018.06.033","article-title":"(2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray","volume":"139","author":"Chou","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109272_bib15","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mp.2012.77","article-title":"The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner","volume":"18","author":"Clarke","year":"2013","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrn2867","article-title":"Long-term depression in the CNS","volume":"11","author":"Collingridge","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109272_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajp.2017.01.025","article-title":"The neurobiology of depression: an integrated view","volume":"27","author":"Dean","year":"2017","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib18","first-page":"1","article-title":"Probiotics supplementation and brain-derived neurotrophic factor (BDNF): a systematic review and meta-analysis of randomized controlled trials","author":"Dehghani","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109272_bib19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/ALN.0b013e3181ed09a2","article-title":"Taming the ketamine tiger","volume":"113","author":"Domino","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2022.109272_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jad.2015.03.032","article-title":"Enrichment pathway analysis. The inflammatory genetic background in Bipolar Disorder","volume":"179","author":"Drago","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109272_bib22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","article-title":"Synaptic dysfunction in depression: potential therapeutic targets","volume":"338","author":"Duman","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109272_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tins.2011.11.004","article-title":"Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents","volume":"35","author":"Duman","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109272_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02706-20","article-title":"Fusobacterium nucleatum secretes outer membrane vesicles and promotes intestinal inflammation","volume":"12","author":"Engevik","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.neuropharm.2022.109272_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jcmgh.2020.08.002","article-title":"Human-derived Bifidobacterium dentium modulates the mammalian serotonergic system and gut-brain Axis","volume":"11","author":"Engevik","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.neuropharm.2022.109272_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1073\/pnas.1814709116","article-title":"Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine","volume":"116","author":"Fukumoto","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109272_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.116.239228","article-title":"Antidepressant potential of (R)-Ketamine in rodent models: comparison with (S)-Ketamine","volume":"361","author":"Fukumoto","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109272_bib28","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/gut.2006.117176","article-title":"Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation","volume":"56","author":"Gareau","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2022.109272_bib29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12866-018-1373-7","article-title":"Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties","volume":"18","author":"Getachew","year":"2018","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.neuropharm.2022.109272_bib30","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1176\/appi.ajp.2016.16040411","article-title":"Detrimental side effects of repeated ketamine infusions in the brain","volume":"173","author":"Hashimoto","year":"2016","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib31","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/14728222.2016.1238899","article-title":"Ketamine's antidepressant action: beyond NMDA receptor inhibition","volume":"20","author":"Hashimoto","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.neuropharm.2022.109272_bib32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/pcn.12902","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective","volume":"73","author":"Hashimoto","year":"2019","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109272_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113935","article-title":"Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine","volume":"177","author":"Hashimoto","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109272_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109207","article-title":"A bibliometric analysis of research on (R)-ketamine from 2002 to 2021","volume":"218","author":"He","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109272_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114892","article-title":"Mechanisms of ketamine and its metabolites as antidepressants","volume":"197","author":"Hess","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109272_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0022-3956(94)90017-5","article-title":"The combined dexamethasone\/CRH test: a refined laboratory test for psychiatric disorders","volume":"28","author":"Heuser","year":"1994","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2022.109272_bib37","first-page":"2775","article-title":"[Phencyclidine--angel dust]","volume":"125","author":"H\u00f8iseth","year":"2005","journal-title":"Tidsskr. Nor. Laegeforen"},{"key":"10.1016\/j.neuropharm.2022.109272_bib38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pbb.2018.12.001","article-title":"Role of Actinobacteria and Coriobacteriia in the antidepressant effects of ketamine in an inflammation model of depression","volume":"176","author":"Huang","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2022.109272_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00088-x","article-title":"Transplantation of fecal microbiota from patients with inflammatory bowel disease and depression alters immune response and behavior in recipient mice","volume":"11","author":"Jang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109272_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31764-0","article-title":"Immobilization stress-induced Escherichia coli causes anxiety by inducing NF-\u03baB activation through gut microbiota disturbance","volume":"8","author":"Jang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109272_bib41","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1038\/sj.npp.1301137","article-title":"Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus","volume":"31","author":"Kaneko","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109272_bib42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.annepidem.2016.02.008","article-title":"Brain-gut-microbiota axis: challenges for translation in psychiatry","volume":"26","author":"Kelly","year":"2016","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.neuropharm.2022.109272_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.31","article-title":"Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome","volume":"7","author":"Kiraly","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109272_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2177","article-title":"Gut microbiota variations in patients diagnosed with major depressive disorder-A systematic review","volume":"11","author":"Knudsen","year":"2021","journal-title":"Brain Behav."},{"key":"10.1016\/j.neuropharm.2022.109272_bib45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neubiorev.2017.03.007","article-title":"Serotonin and neuroplasticity - links between molecular, functional and structural pathophysiology in depression","volume":"77","author":"Kraus","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2022.109272_bib46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00406-020-01110-5","article-title":"Intravenous arketamine for treatment-resistant depression: open-label pilot study","volume":"271","author":"Leal","year":"2021","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109272_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14346","article-title":"Direct and indirect mechanisms by which the gut microbiota influence host serotonin systems","author":"Legan","year":"2022","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2022.109272_bib48","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109272_bib49","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3389\/fphar.2019.01702","article-title":"Ketamine alleviates postoperative depression-like symptoms in susceptible mice: the role of BDNF-TrkB signaling","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109272_bib50","article-title":"Akkermansia muciniphila exerts strain-specific effects on DSS-induced ulcerative colitis in mice","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.neuropharm.2022.109272_bib51","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41398-021-01689-w","article-title":"Proteomics analysis of the gut-brain axis in a gut microbiota-dysbiosis model of depression","volume":"11","author":"Liu","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109272_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109250","article-title":"A role of microRNA-149 in the prefrontal cortex for prophylactic actions of (R)-ketamine in inflammation model","volume":"219","author":"Ma","year":"2022","journal-title":"Neuropharmacology"},{"issue":"Suppl. l","key":"10.1016\/j.neuropharm.2022.109272_bib53","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1097\/MCG.0b013e31822fecfe","article-title":"Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics","volume":"45","author":"Macfarlane","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2022.109272_bib54","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/jm00326a019","article-title":"The synthesis of phencyclidine and other 1-ARYLCYCLOHEXYLAMINES","volume":"8","author":"Maddox","year":"1965","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2022.109272_bib55","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41598-018-38018-z","article-title":"Clostridium ramosum regulates enterochromaffin cell development and serotonin release","volume":"9","author":"Mandi\u0107","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109272_bib56","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2165\/11633130-000000000-00000","article-title":"Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date","volume":"72","author":"Mathews","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2022.109272_bib57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0304-3959(94)00170-J","article-title":"Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain","volume":"61","author":"Mathisen","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2022.109272_bib58","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jad.2021.09.038","article-title":"Estimating the global treatment rates for depression: a systematic review and meta-analysis","volume":"295","author":"Mekonen","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109272_bib59","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109272_bib61","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/mp.2013.105","article-title":"Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)","volume":"19","author":"Molendijk","year":"2014","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib62","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/dta.1620","article-title":"From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs","volume":"6","author":"Morris","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.neuropharm.2022.109272_bib63","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1017\/S0033291715001506","article-title":"Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial","volume":"45","author":"Murrough","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2022.109272_bib64","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib65","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0022-3565(25)11430-4","article-title":"Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors","volume":"260","author":"Oye","year":"1992","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109272_bib66","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.biopsych.2017.10.020","article-title":"Common neurotransmission recruited in (R,S)-Ketamine and (2R,6R)-hydroxynorketamine-induced sustained antidepressant-like effects","volume":"84","author":"Pham","year":"2018","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib67","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuropharm.2016.05.010","article-title":"Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB\/cJ mice","volume":"112","author":"Pham","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109272_bib68","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","article-title":"Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression","volume":"66","author":"Price","year":"2009","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16060-7","article-title":"Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model","volume":"7","author":"Qu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109272_bib70","article-title":"Efficacy and safety of intranasal esketamine in treatment-resistant depression in adults: a systematic review","volume":"13","author":"Sapkota","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.neuropharm.2022.109272_bib71","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ijnp\/pyx108","article-title":"Lack of antidepressant effects of (2R,6R)-hydroxynorketamine in a rat learned helplessness model: comparison with (R)-Ketamine","volume":"21","author":"Shirayama","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109272_bib72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fendo.2020.00025","article-title":"The role of short-chain fatty acids from gut microbiota in gut-brain communication","volume":"11","author":"Silva","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neuropharm.2022.109272_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/nu10121939","article-title":"Faecal short chain fatty acids profile is changed in polish depressive women","volume":"10","author":"Skonieczna-\u017bydecka","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.neuropharm.2022.109272_bib74","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/npp.2017.94","article-title":"Dose-related effects of adjunctive ketamine in Taiwanese patients with treatment-resistant depression","volume":"42","author":"Su","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109272_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031172","article-title":"How microbes affect depression: underlying mechanisms via the gut-brain Axis and the modulating role of probiotics","volume":"23","author":"Suda","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109272_bib76","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2016.03.003","article-title":"Antidepressant-like effects of sodium butyrate and its possible mechanisms of action in mice exposed to chronic unpredictable mild stress","volume":"618","author":"Sun","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109272_bib77","doi-asserted-by":"crossref","first-page":"8415","DOI":"10.1021\/acs.jafc.8b02462","article-title":"Clostridium butyricum attenuates chronic unpredictable mild stress-induced depressive-like behavior in mice via the gut-brain Axis","volume":"66","author":"Sun","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.neuropharm.2022.109272_bib78","article-title":"Alleviation of anxiety\/depressive-like behaviors and improvement of cognitive functions by Lactobacillus plantarum WLPL04 in chronically stressed mice","author":"Sun","year":"2021","journal-title":"Can. J. Infect. Dis. Ned. Microbiol. 2021"},{"key":"10.1016\/j.neuropharm.2022.109272_bib79","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/nmo.12804","article-title":"Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models","volume":"28","author":"Takada","year":"2016","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2022.109272_bib80","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2005.07.036","article-title":"Effects of intraduodenal injection of Lactobacillus johnsonii La1 on renal sympathetic nerve activity and blood pressure in urethane-anesthetized rats","volume":"389","author":"Tanida","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109272_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.755481","article-title":"Consumption of butylated starch alleviates the chronic restraint stress-induced neurobehavioral and gut barrier deficits through reshaping the gut microbiota","volume":"12","author":"Tian","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109272_bib82","first-page":"4004","article-title":"Apigenin ameliorates post-stroke cognitive deficits in rats through histone acetylation-mediated neurochemical alterations","volume":"23","author":"Tu","year":"2017","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res. : Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.neuropharm.2022.109272_bib83","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S2215-0366(19)30394-3","article-title":"Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval","volume":"6","author":"Turner","year":"2019","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib84","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/1567202612666150728121121","article-title":"Sodium butyrate, a histone deacetylase inhibitor, reverses behavioral and mitochondrial alterations in animal models of depression induced by early- or late-life stress","volume":"12","author":"Valvassori","year":"2015","journal-title":"Curr. Neurovascular Res."},{"key":"10.1016\/j.neuropharm.2022.109272_bib85","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1113\/JP276431","article-title":"Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations","volume":"596","author":"van de Wouw","year":"2018","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2022.109272_bib86","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/npp.2013.71","article-title":"NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice","volume":"38","author":"Walker","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109272_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109139","article-title":"Effects of (R)-ketamine on reduced bone mineral density in ovariectomized mice: a role of gut microbiota","volume":"213","author":"Wan","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109272_bib88","article-title":"Psychoactive effects of Lactobacillus johnsonii against restraint stress-induced memory dysfunction in mice through modulating intestinal inflammation and permeability-a study based on the gut-brain Axis hypothesis","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109272_bib89","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jad.2019.09.064","article-title":"Antibiotic-induced microbiome depletion is associated with resilience in mice after chronic social defeat stress","volume":"260","author":"Wang","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109272_bib90","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbr.2019.01.057","article-title":"Ketamine improved depressive-like behaviors via hippocampal glucocorticoid receptor in chronic stress induced- susceptible mice","volume":"364","author":"Wang","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109272_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105635","article-title":"(R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: a role of gut-microbiota-brain axis","volume":"165","author":"Wang","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2022.109272_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104762","article-title":"(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: beyond depression","volume":"139","author":"Wang","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2022.109272_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173226","article-title":"Gut microbiota is involved in the antidepressant-like effect of (S)-norketamine in an inflammation model of depression","volume":"207","author":"Wang","year":"2021","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2022.109272_bib94","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","article-title":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","volume":"27","author":"Wei","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib95","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainresbull.2022.02.008","article-title":"Brain-spleen axis in health and diseases: a review and future perspective","volume":"182","author":"Wei","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2022.109272_bib96","series-title":"Depression","year":"2021"},{"key":"10.1016\/j.neuropharm.2022.109272_bib97","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib98","article-title":"CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation","volume":"34","author":"Wu","year":"2021","journal-title":"Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib99","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41386-018-0084-y","article-title":"(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice","volume":"43","author":"Yamaguchi","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109272_bib100","article-title":"Bifidobacterium in the gut microbiota confer resilience to chronic social defeat stress in mice","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109272_bib101","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/03009734.2012.724118","article-title":"Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test","volume":"118","author":"Yang","year":"2013","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.neuropharm.2022.109272_bib102","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.biopsych.2018.05.007","article-title":"AMPA receptor activation-independent antidepressant actions of ketamine metabolite (S)-Norketamine","volume":"84","author":"Yang","year":"2018","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib103","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.biopsych.2016.12.020","article-title":"(R)-Ketamine shows greater potency and longer lasting antidepressant effects than its metabolite (2R,6R)-hydroxynorketamine","volume":"82","author":"Yang","year":"2017","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib104","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/s41398-017-0031-4","article-title":"Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model","volume":"7","author":"Yang","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109272_bib105","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109272_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109272_bib107","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume":"161","author":"Yano","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2022.109272_bib108","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1038\/mp.2017.239","article-title":"Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit","volume":"23","author":"Yao","year":"2018","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib109","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/s41380-021-01377-7","article-title":"Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine","volume":"27","author":"Yao","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172876","article-title":"(S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression","volume":"191","author":"Yokoyama","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2022.109272_bib111","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109272_bib112","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109272_bib113","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib114","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109272_bib115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1053\/j.gastro.2020.09.036","article-title":"Elucidation of Proteus mirabilis as a key bacterium in crohn's disease inflammation","volume":"160","author":"Zhang","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2022.109272_bib116","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","article-title":"R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2022.109272_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109219","article-title":"Arketamine, a new rapid-acting antidepressant: a historical review and future directions","volume":"218","author":"Zhang","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109272_bib118","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1038\/s41598-018-22449-9","article-title":"Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109272_bib119","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/mp.2016.44","article-title":"Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism","volume":"21","author":"Zheng","year":"2016","journal-title":"Mol. Psychiatr."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822003318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822003318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:21:33Z","timestamp":1758439293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822003318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":119,"alternative-id":["S0028390822003318"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109272","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depression and antidepressant effects of ketamine and its metabolites: The pivotal role of gut microbiota","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109272"}}